Northwestern Mutual Wealth Management’s Actuate Therapeutics ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.4K Hold
18,518
– – ﹤0.01% 3058
2026
Q2
$28.3K Sell
18,518
-12,878
-41% -$29.8K ﹤0.01% 2736
2026
Q1
$86K Buy
31,396
+12,878
+70% +$53.4K ﹤0.01% 2230
2025
Q4
$113K Sell
18,518
-783
-4% -$5.38K ﹤0.01% 2086
2025
Q3
$129K Buy
19,301
+783
+4% +$5.68K ﹤0.01% 1959
2025
Q2
$113K Buy
18,518
+15,393
+493% +$134K ﹤0.01% 1962
2025
Q1
$21.2K Buy
+3,125
New +$25.1K ﹤0.01% 2489

Other funds holding ACTU

Northwestern Mutual Wealth Management's ACTU Position: Q3 2026 in Review

Northwestern Mutual Wealth Management held its Actuate Therapeutics (ACTU) position steady in Q3 2026 at 18,518 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

Northwestern Mutual Wealth Management first reported a position in ACTU in Q1 2025 and has held it in 7 quarters since. The position peaked at $129K in Q3 2025. 40 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.

  • Northwestern Mutual Wealth Management held 18,518 shares of Actuate Therapeutics worth $14.4K as of Q3 2026.
  • Northwestern Mutual Wealth Management left its Actuate Therapeutics share count unchanged in Q3 2026.
  • Actuate Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q3 2026, its #3058 holding.
  • Northwestern Mutual Wealth Management first reported a position in Actuate Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Northwestern Mutual Wealth Management's Actuate Therapeutics position peaked at $129K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.